Between 1970 and 1998, 90 cases of male breast cancer with available pathol
ogical material were retrieved. The disease often presented in aged patient
s (median-66 years) and as advanced stage (stage III/IV-51%). Excluding sta
ge IV disease. the neoplasia were predominantly ductal invasive carcinomas,
NOS (not otherwise specified) (92%), grade I and grade 2 (94%), positive f
or estrogen and progesterone receptors (72% and 74%), negative for androgen
receptors (100%), p53 negative (95%), c-erbB-2 negative (88%) and DNA aneu
ploid (73%). Assessment of disease outcome is determined by stage at time o
f diagnosis, and axillary lymph node status was the only parameter found to
have a statistically significant correlation with either disease-free inte
rval or overall survival (p < 0.001) by multivariate analysis. Clinically u
seful information on the probability of relapse can be added by determining
c-erbB-2 (p = 0.02) an progesterone receptors (p = 0.04) in stage III and
tumor ploidy (p = 0.04) in pN1 subgroups of patients.